STARSCAPE-OLE: A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

Sponsor
Hoffmann-La Roche (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04594707
Collaborator
(none)
700
211
1
88
3.3
0

Study Details

Study Description

Brief Summary

This study will evaulate the long-term safety, efficacy and pharmacokinetics (PK) of recombinant human pentraxin-2 (rhPTX-2; PRM-151) zinpentraxin alfa, administered by intravenous (IV) infusion to participants with idiopathic pulmonary fibrosis (IPF).

Condition or Disease Intervention/Treatment Phase
  • Drug: PRM-151 (Zinpentraxin Alfa)
Phase 3

Detailed Description

This study is being conducted for the treatment of eligible participants who have taken part in Study PRM-151-202 and received the open-label study drug or completed the Phase III Study WA42293 with PRM-151. Participants who have discontinued treatment from or have completed Study WA42293 and do not want to receive PRM-151 in this study, will be invited to enroll in survival follow-up.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
700 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Phase III Open-label Extension Study to Evaluate Long-term Safety and Efficacy of PRM-151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Actual Study Start Date :
Aug 30, 2021
Anticipated Primary Completion Date :
Dec 29, 2028
Anticipated Study Completion Date :
Dec 29, 2028

Arms and Interventions

Arm Intervention/Treatment
Experimental: PRM-151

Corhort A: Participants entering, following participation in study PRM-151-202. Cohort B: Participants entering, following participation in study WA42293.

Drug: PRM-151 (Zinpentraxin Alfa)
Cohort A: Participants will receive three loading doses of open-label PRM-151 on days 1, 3, and 5, then one infusion every 4 weeks (Q4W). 10 mg/kg of PRM 151 will be administered by intravenous (IV) infusion over 60 minutes on days 1, 3, and 5, then one infusion every 4 weeks. Cohort B: Participants previously randomized to the placebo in WA42293 will receive study medication in the three loading doses on days 1, 3 and 5 in a blinded fashion. All three doses will contain PRM-151. Participants previously randomized to the treatment arm in WA42293 will receive study medication in the three loading doses on days 1, 3 and 5 in a blinded fashion. One of the three doses will contain PRM-151, whereas two doses will contain placebo.
Other Names:
  • Zinpentraxin Alfa
  • Outcome Measures

    Primary Outcome Measures

    1. Percentage of Participants with Adverse Events (AE) [From baseline until 8 weeks after the final dose]

      Severity will be determined according to the 5-point severity scale (National Cancer Institute Common Terminology Criteria for Adverse Events, Version 5.0 [NCI CTCAE, v.5.0]).

    2. Percentage of Participants with Infusion Related Reactions (IRRs) and other AEs of Special Interest [From baseline until 8 weeks after the final dose]

    3. Percentage of of Participants Permanently Discontinuing Study Treatment due to AEs [From baseline until 8 weeks after the final dose]

    4. Change from Baseline in Targeted Clinical Laboratory Test Results [From baseline until 8 weeks after the final dose]

    Secondary Outcome Measures

    1. Annual Rate of Change in Forced Vital Capacity (FVC) (mL) [From baseline until study completion (up tp 4 years)]

    2. Annual Rate of Change in 6-Minute Walk Distance (6MWD) [From baseline until study completion (up tp 4 years)]

    3. Annual Rate of Change in FVC% Predicted [From baseline until study completion (up tp 4 years)]

    4. Annual Rate of Change in Carbon Monoxide Diffusing Capacity (DLCO) [From baseline until study completion (up tp 4 years)]

    5. Time to Disease Progression [From the time of randomization until disease progression or death (up tp 4 years)]

      Time to first occurrence of >=10% absolute decline in % predicted FVC, >=15% relative decline in 6MWD, or death

    6. Survival [Every 6 Months and at study completion (up to 4 years)]

    7. IPF-related Mortality [Every 6 Months and at study completion (up to 4 years)]

    8. Respiratory-related Mortality [Every 6 Months and at study completion (up to 4 years)]

    9. Plasma Concentrations of PRM-151 at Specified Timepoints [Days 1, 3 and 5, Weeks 4, 12 and 24]

    10. Prevalence of Anti-drug Antibodies (ADAs) to PRM-151 at Baseline [Baseline (Day 1)]

    11. Percentage of Participants with ADAs During the Study [Weeks 4, 12 and 24]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Taken part in either of the prior PRM-151 studies: PRM-151-202 or WA42293.

    • For women of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraception.

    • For men: agreement to remain abstinent (refrain from heterosexual intercourse) or use a condom, and agreement to refrain from donating sperm.

    Exclusion Criteria:
    • Acute respiratory or systemic bacterial, viral, or fungal infection at the first visit of the OLE, or within 2 weeks of the first visit for patients joining Cohort A (from Study PRM-151-202).

    • History of smoking within 3 months prior to the first visit in the OLE.

    • History of alcohol or substance use disorder within 2 years prior to the first visit of the OLE or known or suspected active alcohol or substance-use disorder.

    • History of severe allergic reaction or anaphylactic reaction to PRM-151.

    • Clinically significant abnormality on ECG during eligibility assessment that, in the opinion of the investigator, may pose an additional risk in administering study drug to the participant.

    • Prolonged corrected QT interval > 450 ms (for men) or > 470 ms (for women) based on the Fridericia correction formula.

    • Clinically significant laboratory test abnormalities (hematology, serumchemistry, and urinalysis) that, in the opinion of the investigator, may pose an additional risk in administering study drug to the participant.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UCSF Medical Center San Francisco California United States 94143-0748
    2 National Jewish Health Medical Center Denver Colorado United States 80045-2541
    3 Yale New Haven Hospital New Haven Connecticut United States 06510
    4 Meris Clinical Research Brandon Florida United States 33511-5719
    5 Florida Lung, Asthma and Sleep Specialists (FLASS) - Celebration Celebration Florida United States 34747-1818
    6 Sarasota County Public Hospital Sarasota Florida United States 34239
    7 Bassetti Medical Research, Inc Sebring Florida United States 33870-1216
    8 Renstar Medical Research Wesley Chapel Florida United States 33544
    9 Florida Pulmonary Research Institute, LLC Winter Park Florida United States 32789
    10 NorthShore University HealthSystem Evanston Illinois United States 60201
    11 University of Iowa Hospitals and Clinics; Investigational Drug Services Iowa City Iowa United States 52242
    12 University of Kansas Medical Center Kansas City Kansas United States 66160
    13 University of Louisville Health Sciences Center Louisville Kentucky United States 40202
    14 University of Minnesota Medical Center Minneapolis Minnesota United States 29425-8911
    15 Mayo Clinic Rochester Rochester Minnesota United States 55902
    16 The Lung Research Center Chesterfield Missouri United States 63017-3625
    17 Washington University Saint Louis Missouri United States 63128
    18 University of Nebraska Medical Center Omaha Nebraska United States 68198-0600
    19 Albany Med College Albany New York United States 12208
    20 Lenox Hill Hospital New York New York United States 10075
    21 American Health Research Inc. Charlotte North Carolina United States 28277
    22 Pulmonix Research Greensboro North Carolina United States 27403-1127
    23 Oregon Health and Science University Portland Oregon United States 97239
    24 Jefferson University Physicians (JUP) - Jefferson Pulmonary Philadelphia Pennsylvania United States 19107
    25 University of Pittsburgh Medical Center Pittsburgh Pennsylvania United States 15213
    26 SleepMed of South Carolina Columbia South Carolina United States 29201-2953
    27 Lowcountry Lung and Critical Care North Charleston South Carolina United States 29406
    28 Vanderbilt University Medical Center Nashville Tennessee United States 37212
    29 Metroplex Pulmonology & Sleep Center McKinney Texas United States 75069
    30 University Of Utah Hosp & Clin; Investigational Pharmacy Salt Lake City Utah United States 84132
    31 Inova Fairfax Hospital Falls Church Virginia United States 22031
    32 Hospital Britanico de Buenos Aires Ciudad Autonoma Buenos Aires Argentina C1284AEB
    33 Centro de Alergia y Enfermedades Respiratorias Ciudad Autonoma Buenos Aires Argentina C1414AIF
    34 Fundacion Respirar (Centro Medico Dra. De Salvo) Ciudad Autonoma Buenos Aires Argentina C1426ABP
    35 Instituto de Medicina Respiratoria, IMeR; Clinic/Outpatient Facility Córdoba Argentina X5003DCE
    36 Hospital Universitario Austral Derqui-Pilar Argentina B1629ODT
    37 Centro Medico de Enfermedades Respiratorias (CEMER) Florida Argentina
    38 Centro de estudios respiratorios Mar Del Plata Argentina B7600CLK
    39 INSARES Mendoza, Mendoza City Argentina M5500CCG
    40 Fundacion Scherbovsky Mendoza Argentina M5500AYB
    41 Centro Respiratorio Infantil Rosario Argentina S2000BRH
    42 Investigaciones en Patologias Respiratorias San Miguel de Tucuman Argentina T4000IAR
    43 Royal Prince Alfred Hospital Camperdown New South Wales Australia 2050
    44 Cairns Base Hospital; Cancer Care Centre Cairns Queensland Australia 4870
    45 Lung Research Queensland Nundah Queensland Australia 4101
    46 Princess Alexandra Hospital Woolloongabba Queensland Australia 4102
    47 The Queen Elizabeth Hospital Woodville South Australia Australia 5011
    48 Monash Medical Centre; Medicine Melbourne Victoria Australia 3186
    49 The Alfred Hospital Prahan Victoria Australia 3181
    50 ULB Hôpital Erasme Brussels Belgium 1070
    51 Cliniques Universitaires Saint-Luc; Pharmacy Bruxelles Belgium 1200
    52 UZ Leuven Leuven Belgium 3000
    53 C. H. U. Sart-Tilman; Laboratory Liège Belgium 4000
    54 CHU UCL Namur / site Godinne Yvoir Belgium B5530
    55 Kelowna Respiratory and Allergy Clinic Kelowna British Columbia Canada V1W 1V3
    56 The Rhema Research Institute Owen Sound Ontario Canada N4K 6M9
    57 Peking Union Medical College Hospital; Pharmacy Beijing City China 100730
    58 Beijing Friendship Hospital Affiliated of Capital University of Medical Science Beijing Shi China 100050
    59 The Second Hospital of Jilin University Changchun China 130041
    60 Anhui Provincial Hospital Hefei China 230001
    61 Tianjin Medical University General Hospital Tianjin China 300052
    62 Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan City China 430030
    63 Wuxi People's Hospital Wuxi China 214023
    64 Fakultni nemocnice Brno Brno Czechia 613 00
    65 Nemocnice Na Bulovce Prague Czechia 180 01
    66 Thomayerova nemocnice; Lekarna - pavilon H Praha 4 Czechia 140 00
    67 Krajska nemocnice T. Bati a.s.; Neurologicke oddeleni Zlin Czechia 760 01
    68 Hopital Avicenne Bobigny France 93000
    69 Centre Hospitalier Regional Universitaire de Brest - Hopital de la Cavale Blanche Brest France 29200
    70 Hopital Louis Pradel Bron France 69677
    71 CHU Hopitaux de Bordeaux CHU Hopitaux De Bordeaux France 33000
    72 CHU Dijon Bourgogne Hôpital François Mitterand Dijon France 21000
    73 CHU de Grenoble - Hôpital André Michallon; Pole Pharmacie La Tronche France 38700
    74 Centre Hospitalier Regional Universitaire de Lille Lille France
    75 Servie de Pneumologie et centre de Transplantation Pulmonaire Marseille France 13354
    76 CHU Nice - Hôpital Pasteur 2 Nice France 06000
    77 Hopital Bichat Claude Bernard; Hepatologie Gastro Enterologie Paris France 75018
    78 Centre Hospitalier Universitaire de Reims; l'Hopital Maison Blanche Reims France 51092
    79 Centre Hospitalier Universitaire de Rennes Rennes France 35033
    80 CHU Tours - Hôpital Bretonneau Tours France 37044
    81 Evang. Lungenklinik Berlin Klinik für Pneumologie Berlin Germany 13125
    82 Thoraxklinik-Heidelberg gGmbH; Apotheke der Thoraxklinik Heidelberg Germany 69120
    83 Lungenfachklinik Immenhausen Immenhausen Germany 34376
    84 Praxis für Pneumologie Dr. Silke Mronga & Dr. Lukas Jerrentrup Marburg Germany 35037
    85 Krankenhaus Bethanien gGmbH Solingen Germany 42699
    86 Evangelismos Hospital; Endocrinology, Diabetes & Metabolism Athens Greece 10676
    87 National and Kapodistrian University of Athens EKPA Medical School Athens Greece 115 27
    88 University Hospital of Ioannina; Pulmonology Department Ioannina Greece 455 00
    89 University General Hospital of Larissa Larissa Greece 412 21
    90 Athens Medical Center Marousi Greece 151 25
    91 University General Hospital of Patras Patras Greece 265 00
    92 "General hospital of Chest Diseases ""Sotiria"", 7th Pulmonary Clinic " Sotiria Athens Greece 115 27
    93 Prince of Wales Hospital; Dept. of Medicine & Therapeutics Hong Kong Hong Kong
    94 The University of Hong Kong; Queen Mary Hospital Hong Kong Hong Kong
    95 Semmelweis University Budapest Hungary 1081
    96 Debreceni Egyetem Debrecen Hungary 4032
    97 Markusovszky Egyetemi Oktatokorhaz ; SZEMESZET Szombathely Hungary 9700
    98 Szent Borbala Korhaz Tatabánya Hungary 2800
    99 Barzilai Medical Center; Neurology Department Ashkelon Israel 7830604
    100 Shamir medical center Be'er Ya'akov Israel 0070300
    101 Soroka University Medical Center, Psychiatry; Psychiatry Beer Sheva Israel 8410101
    102 Rambam Health Care Campus Haifa Israel 3109600
    103 Edith Wolfson Medical Center Holon Israel 5822012
    104 Hadassah Medical Center Jerusalem Israel 9112000
    105 Meir Medical Center Kfar- Saba Israel 4428164
    106 Rabin Medical Center Petach Tiqwa Israel 4941492
    107 The Chaim Sheba Medical Center Ramat Gan Israel 5211401
    108 Kaplan Medical Center Rehovot Israel 7610001
    109 Tel Aviv Sourasky Medical Center; Department of Neurology Tel Aviv Israel 6423906
    110 Azienda Ospedaliera Papa Giovanni XXIII Bergamo Abruzzo Italy 24060
    111 "AZIENDA OSPEDALIERA DEI COLLI Monaldi-Cotugno-CTO - Pneumologia " Napoli Campania Italy 80131
    112 Azienda Ospedaliera Universitaria Federico II Napoli Campania Italy 80131
    113 Ospedale Morgagni Pierantoni; Patologia clinica Forlì Emilia-Romagna Italy 47100
    114 A.O.U. Policlinico di Modena Modena Emilia-Romagna Italy 40124
    115 Policlinico Tor Vergata - U.O.C. Malattie Apparato Respiratorio Rome Lazio Italy 00133
    116 Fondazione Policlinico Universitario A Gemelli; Servizio di Farmacia Rome Lazio Italy 00168
    117 Ospedale San Giuseppe; U.O. di Pneumologia Milano Lombardia Italy 20123
    118 Asst Santi Paolo E Carlo Milano Lombardia Italy 20142
    119 Fondazione IRCCS Policlinico San Matteo ; Divisione di Ematologia Dipartimento di Onco-Ematologia Pavia Lombardia Italy 27100
    120 Policlinico Riuniti di Foggia - Department of Medical and Surgical Sciences - University of Foggia Foggia Puglia Italy 71122
    121 A.O.U. Sassari; Dip. Medicina Clinica e Sperimentale Sassari Sardegna Italy 07100
    122 Azienda Ospedaliero - Universitaria Policlinico - Vittorio Emanuele Catania Sicilia Italy 95123
    123 Az. Osp. Univ. P. Giaccone; UOC di Pneumologia Palermo Sicilia Italy 90127
    124 Ismett Istituto Mediterraneo Trapianti E Terapie Alta Specializzazione;Pneumologia Palermo Sicilia Italy 90127
    125 AOUC Azienda Ospedaliero-Universitaria Careggi; Neurologia 2 Firenze Toscana Italy 50134
    126 A.O. Univ. Senese Policlinico S. Maria alle Scotte; Dip. Medicina clinica e Scienze Immunologiche Siena Toscana Italy 53100
    127 Azienda Ospedale Universita Di Padova; Divisione Clinicizzata Di Nefrologia 1 Padova Veneto Italy 35128
    128 University of Padova Ca' Foncello Hospital Immunologic & Respiratory Rare Diseases Center Treviso Veneto Italy 31100
    129 Chiba University Hospital Chiba Japan 260-8677
    130 Fukuoka University Hospital Fukuoka Japan 814-0180
    131 Kobe City Medical Center General Hospital Hyogo Japan 650-0047
    132 National Hospital Organization Himeji Medical Center Hyogo Japan 670-8520
    133 Nippon Medical School Musashi Kosugi Hospital Kawasaki-Shi Japan
    134 Nagasaki University Hospital Nagasaki Japan 852-8501
    135 Center Hospital of the National Center for Global Health and Medicine Tokyo Japan 162-0052
    136 The Catholic University of Korea Bucheon St. Mary's Hospital Gyeonggi-do Korea, Republic of 14662
    137 Gacheon University Gil Medical Center Namdong-gu Korea, Republic of 21565
    138 The Catholic University of Korea Yeouido St. Mary's Hospital; Hematology-Oncology Seoul Korea, Republic of (0)7345
    139 Seoul National University Hospital (SNUH) - Medical Oncology Center Seoul Korea, Republic of 03080
    140 Soonchunhyang University Hospital Seoul Korea, Republic of 04401
    141 Asan Medical Center Seoul Korea, Republic of 05505
    142 Samsung Medical Center Seoul Korea, Republic of 06351
    143 Unidad Médica para la Salud Integral UMSI San Nicolás de Los Garza Nuevo LEON Mexico 66465
    144 Unidad de Investigacion CIMA SC Chihuahua Mexico 31200
    145 Centro de Diagnóstico y Tratamiento de Enfermedades Respiratorias, Medica San Isidro Metepec Mexico 52140
    146 Centro Respiratorio de México Mexico Mexico 14050
    147 INER- Instituto Nacional de Enfermedades Respiratorias"Ismae Mexico Mexico 14080
    148 CICC Morelia Morelia Mexico
    149 Sint Antonius Ziekenhuis, locatie Nieuwegein Nieuwegein Netherlands 3430 EM
    150 Erasmus Medisch Centrum Rotterdam Netherlands 3000 CA
    151 Auckland City Hospital Auckland New Zealand 1023
    152 NZ Respiratory & Sleep Institute Auckland New Zealand 1051
    153 University of Otago, Christchurch Christchurch New Zealand 8011
    154 Waikato Hospital; Gastro Research Hamilton New Zealand 3240
    155 Tauranga Hospital Tauranga New Zealand 3143
    156 Helse Bergen HF Haukeland universitetssykehus; Hudavdelingen Bergen Norway 5021
    157 Akershus universitetssykehus Lørenskog Norway 1478
    158 Oslo University Hospital HF, Rikshospitalet Oslo Norway 0424
    159 Hospital de Chancay Chancay Peru 15131
    160 Centrum Medycyny Oddechowej Mroz sp. j. Białystok Poland 15-044
    161 Nasz Lekarz Osrodek Badan Klinicznych Bydgoszcz Poland 85-312
    162 Jagiellonskie Centrum Innowacji Kraków Poland 30-348
    163 SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im. Norberta Barlickiego Uniwersytetu Medycznego w Lodzi Lodz Poland 90-153
    164 Hospital Senhora da Oliveira - Guimarães, E.P.E Guimaraes Portugal 4835-044
    165 CHVNG/E_Unidade 1; Servico de Pneumologia Vila Nova de Gaia Portugal 4434-502
    166 Chelyabinsk Regional Clinical Hospital; Hematology Chelyabinsk Russian Federation 454076
    167 National University Hospital Singapore Singapore 119074
    168 Singapore General Hospital Singapore Singapore 169608
    169 Tan Tock Seng Hospital; Oncology Singapore Singapore 308433
    170 University of Cape Town Lung Institute; Lung Clinical Research Cape Town South Africa 7700
    171 Johese Clinical Research Centurion South Africa 1692
    172 Into Research; Life Groenkloof Hospital Medical Centre Groenkloof South Africa 0181
    173 Vergelegen Medi-Clinic Somerset West South Africa 7130
    174 HUA - Txagorritxu Vitoria Alava Spain 01009
    175 Hospital Univ. Central de Asturias Oviedo Asturias Spain 33006
    176 Hospital Universitario de Bellvitge Hospitalet de Llobregat Barcelona Spain 08907
    177 Hospital Universitario Marques de Valdecilla Santander Cantabria Spain 39008
    178 CHUS - H. Clinico U. de Santiago Santiago de Compostela LA Coruña Spain 15706
    179 Hospital Universitario del Henares Coslada Madrid Spain 28850
    180 Hospital Galdakao-Usansolo Galdakao Vizcaya Spain 48960
    181 Hospital de la Santa Creu i Sant Pau; Servicio de Neumologia Barcelona Spain 08025
    182 Hospital Clinic I Provincial Barcelona Spain 08036
    183 Hospital Germans Trias i Pujol Barcelona Spain 08916
    184 Hospital Virgen de las Nieves; Servicio de Neumologia Granada Spain 18014
    185 Clinica Universidad de Navarra ; Servicio de Farmacia Madrid Spain 28027
    186 Universidad Autonoma de Madrid (UAM) - Hospital Universitario La Paz Madrid Spain 28029
    187 Fundacion Jimenez Diaz-UTE Madrid Spain 28040
    188 Hosp. Clinico San Carlos Madrid Spain 28040
    189 Hospital Universitario 12 de Octubre Madrid Spain 28041
    190 Hospital Clinico Universitario de Salamanca Salamanca Spain 37007
    191 Hospital Clinico Universitario de Valencia Valencia Spain 46010
    192 Buddhist Tzu Chi Dalin General Hospital; Rheumatology Chia-yi Taiwan 622
    193 Kaohsiung Medical University Hospital; Chung-Ho Memorial Hospital Kaoshiung City Taiwan 807
    194 China Medical University Hospital Taichung Taiwan 40447
    195 National Cheng Kung University Hospital Tainan Taiwan 70457
    196 National Taiwan University Hospital Taipei Taiwan 10002
    197 Far Eastern Memorial Hospital; Department of Clinical Pathology Taipei Taiwan 220
    198 Veterans General Hospital - Taichung Xitun Dist. Taiwan 40705
    199 Cukurova Universitesi Tip Fakultesi Balcali Hastanesi; Balcali; Onkologi Adana Turkey 01330
    200 Ankara Universitesi Tip Fakultesi Hastaneleri - Cebeci Hastanesi Ankara Turkey 06620
    201 Uludag Universitesi - Saglik Uygulama ve Arastirrma Merkezi Bursa Turkey 16059
    202 Gaziantep Universitesi Tip Fakultesi Gaziantep Turkey 27310
    203 Yedikule Gogus Hastaliklari ve Gogus Cerrahisi Egitim ve Arastirma Hastanesi Istanbul Turkey 34020
    204 Istanbul Universitesi Onkoloji Enstitüsü Hastanesi İstanbul Turkey 34093
    205 Ege Universitesi Tip Fakultesi Hastanesi Izmir / Turkey 35100
    206 Dokuz Eylul University Faculty of Medicine; Chest Diseases Izmir Turkey 35340
    207 Marmara Universitesi Hastanesi Marmara University Hospital Maltepe Turkey 34854
    208 Eriyes universitesi Tıp Fakultesi Hastanesi Melikgazi/Kayser Turkey 38039
    209 Mersin Universitesi Tip Fakultesi Hastanesi; Tibbi Onkoloji Birimi Mersin Turkey 33110
    210 Akdeniz University Faculty of Medicine Department of Pulmonology Muratpasa/Antalya Turkey 07059
    211 Koc Universitesi (KU) Tip Fakultesi (Koc University School of Medicine) Sariyer Turkey 34450

    Sponsors and Collaborators

    • Hoffmann-La Roche

    Investigators

    • Study Director: Clinical Trials, Hoffmann-La Roche

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hoffmann-La Roche
    ClinicalTrials.gov Identifier:
    NCT04594707
    Other Study ID Numbers:
    • WA42294
    • 2020-001429-30
    First Posted:
    Oct 20, 2020
    Last Update Posted:
    Aug 18, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 18, 2022